01—Abstract
Summary
Summary of the 8-K filed March 2, 2026. Cited figures are marked; the original filing is the authoritative source.
Elevance Health, Inc. (ELV) disclosed in an 8-K filing dated March 2, 2026, that it has been notified by the Centers for Medicare & Medicaid Services (CMS) of its intent to impose intermediate sanctions.
These sanctions include suspending enrollment of new Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug (MA-PD) plans and halting certain communication activities to Medicare beneficiaries. The sanctions are slated to take effect on March 31, 2026, pending satisfactory resolution of the issues identified by CMS. The core of the CMS action relates to alleged noncompliance with Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023.
Elevance Health has indicated that it revised its practices in April 2023 following updated regulatory guidance and is actively engaged with CMS to address these concerns. Importantly, the sanctions do not affect current MA-PD members' benefits or plans.
02—Key points
Key Highlights
- CMS intends to impose intermediate sanctions on Elevance Health's MA-PD plans, suspending new enrollment and certain communications.
- The sanctions are scheduled to begin on March 31, 2026, unless issues are resolved.
- The alleged noncompliance relates to risk adjustment data submissions for services prior to April 3, 2023.
- Elevance Health revised its practices in April 2023 and is cooperating with CMS.
- Current MA-PD members' benefits and plans are unaffected by these proposed sanctions.
03—Questions
Frequently Asked Questions
What is the primary reason for the potential sanctions from CMS?
The potential sanctions stem from allegations of noncompliance by Elevance Health with certain Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023.
Will current Medicare Advantage members lose their benefits?
No, the filing explicitly states that the suspension of enrollment and communication activities does not impact the benefits or plans of current MA-PD members.
What steps is Elevance Health taking in response to CMS's notice?
Elevance Health is engaging with CMS to address the concerns raised and is committed to working cooperatively with the agency to resolve the identified issues. The company also noted that it revised its practices in April 2023 following updated regulatory guidance.
When are these sanctions expected to take effect?
The sanctions are scheduled to take effect on March 31, 2026, unless CMS determines that the issues identified have been satisfactorily addressed by Elevance Health.
04—Continue